In the phase II JADA study, there was a trend towards significance for decreases of small, medium small and very small LDL particles at 12 weeks 12 ; in RA-BEAM these differences were all significant.
← all excerpts
Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.
1
—
—